The project is about the establishment of a complex which will enable to conduct bio equivalence studies for generic drugs.Drug producers need to get the evidence of compliance of generic drug to brand one. The only way to prove it is bio equivalence study results. Drug registration bodies in all countries require Dossiers, as an evidence that this generic drug is equivalent to brand one. It is impossible to register generics without Dossiers.Bio equivalence study will assure that new generic is safe, efficient and corresponds to quality requirements.The project implementation will involve:
• Clinic for volunteers /for in vivo studies,
• Analytical laboratory /for blood sample analyses,
• R&D department /for project management, statistical analyses, report writing and Dossiers design.
Access to the information and documents contained in this website is provided as a public information by the Ministry of Economic Development and Investments of the Republic of Armenia. Statistics, data, and financial indicators are prepared and presented by owners of investment projects. The information presented does not make liable or necessarily reflect the views of the Ministry of Economic Development and Investments of the Republic of Armenia. The Ministry of Economic Development and Investments of the Republic of Armenia makes no warranties, either express or implied, concerning the investment projects profitability, implementation time framework, initial calculations or suitability of investment projects.
The mention of names of specific companies or products (whether or not indicated as registered) does not imply any intention to infringe proprietary rights, nor should it be construed as an endorsement or recommendation on the part of the Ministry of Economic Development and Investments of the Republic of Armenia.